The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Complementary and Alternative Medicine Treatments for Children with Autism Spectrum Disorders
Open accessAbstract
SYNOPSIS Complementary and alternative medical treatments are commonly used for children with autism spectrum disorders. This review discusses the evidence supporting the most frequently used treatments, including categories of mind-body medicine, energy medicine, biologically based, manipulative and body-based practices, with the latter two the most commonly selected by families. It is important for clinical providers to understand the evidence for efficacy (or lack thereof) and potential side effects. Some CAM practices have evidence to reject their use, such as secretin, others have emerging evidence to support their use, like melatonin. Most treatments, however, have not been adequately studied and do not have evidence to support their use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence based medicine: what it is and what it isn't
Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996) · BMJ · doi:10.1136/bmj.312.7023.71 · Cited by 15,769
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492
Gastrointestinal Microflora Studies in Late‐Onset Autism
Finegold, S. M., Molitoris, D., Song, Y., Liu, C., Vaisanen, M., Bolte, E., McTeague, M., Sandler, R., Wexler, H., Marlowe, E. M., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/341914 · Cited by 742
Chauhan, A., & Chauhan, V. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.007 · Cited by 656
Oberman, L. M., & Ramachandran, V. S. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.2.310 · Cited by 630 · cited 1×
“This research tool is currently being used to examine the potential overconnectivity of cortical neurons in autism [110] and to examine neurologic function in other disorders such as ADHD [111].”
MethodInternet survey of treatments used by parents of children with autism.
Green, V. A., Pituch, K. A., Itchon, J., Choi, A., O’Reilly, M., & Sigafoos, J. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2004.12.002 · Cited by 617
Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500701 · Cited by 614 · cited 1×
“Sandler and colleagues [98] reported short-term behavioral improvement in 11 children treated with oral vancomycin.”
BackgroundPardo, C. A., & Eberhart, C. G. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00102.x · Cited by 514
Abnormal melatonin synthesis in autism spectrum disorders
Melke, J., Goubran Botros, H., Chaste, P., Betancur, C., Nygren, G., Anckarsäter, H., Rastam, M., Ståhlberg, O., Gillberg, I. C., Delorme, R., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002016 · Cited by 511 · cited 1×
“Clinical studies have demonstrated abnormalities in melatonin production or release in individuals with ASD [34].”
BackgroundChauhan, A., Chauhan, V., Brown, W. T., & Cohen, I. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.038 · Cited by 424
Amminger, G. P., Berger, G. E., Schäfer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.007 · Cited by 355 · cited 1×
“Recently, Amminger and colleagues [47] reported improvement in behavior following a randomized double-blind, placebo-controlled, 6-week pilot trial of oral supplementation in 13 children with ASD with severe behavior difficulties.”
BackgroundHow environmental and genetic factors combine to cause autism: A redox/methylation hypothesis
Deth, R., Muratore, C., Benzecry, J., Power-Charnitsky, V.-A., & Waly, M. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2007.09.010 · Cited by 325
Effects of tryptophan depletion in drug-free adults with autistic disorder
McDougle, C. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110029004 · Cited by 301
Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder
Tordjman, S., Anderson, G. M., Pichard, N., Charbuy, H., & Touitou, Y. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.003 · Cited by 296
Evidence of Toxicity, Oxidative Stress, and Neuronal Insult in Autism
Kern, J. K., & Jones, A. M. (2006) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400600882079 · Cited by 265
Parker, S. K., Schwartz, B., Todd, J., & Pickering, L. K. (2004) · Pediatrics · doi:10.1542/peds.2004-0434 · Cited by 242
SCHAB, D. W., & TRINH, N.-H. T. (2004) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200412000-00007 · Cited by 234
Circulating autoantibodies to neuronal and glial filament proteins in autism
Singh, V. K., Warren, R., Averett, R., & Ghaziuddin, M. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00045-3 · Cited by 234
The Effect of Sugar on Behavior or Cognition in Children: A Meta-analysis
Wolraich, M. L. (1995) · JAMA · doi:10.1001/jama.1995.03530200053037 · Cited by 214
Owens, J. A., Rosen, C. L., & Mindell, J. A. (2003) · PEDIATRICS · doi:10.1542/peds.111.5.e628 · Cited by 214
ASHWOOD, P., ANTHONY, A., TORRENTE, F., & WAKEFIELD, A. J. (2004) · Journal of Clinical Immunology · doi:10.1007/s10875-004-6241-6 · Cited by 212
Jyonouchi, H., Geng, L., Ruby, A., & Zimmerman-Bier, B. (2005) · Neuropsychobiology · doi:10.1159/000084164 · Cited by 201
A preliminary trial of ascorbic acid as supplemental therapy for autism
Dolske, M. C., Spollen, J., McKay, S., Lancashire, E., & Tolbert, L. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90058-z · Cited by 168 · cited 1×
“Dolske and colleagues [37] reported positive results of decreased stereotyped behavior in a 30-week, double-blind, placebo-controlled trial in 18 children with ASD.”
BackgroundEarly medical history of children with autism spectrum disorders
NIEHUS, R., & LORD, C. (2006) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200604002-00010 · Cited by 152
Levy, S. E., Souders, M. C., Ittenbach, R. F., Giarelli, E., Mulberg, A. E., & Pinto-Martin, J. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.013 · Cited by 130
Self-citation
Cited by
Lord, C., Elsabbagh, M., Baird, G., & Veenstra-Vanderweele, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31129-2 · Cited by 2,819
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
Self-citationLevy, S. E., Mandell, D. S., & Schultz, R. T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61376-3 · Cited by 651
Self-citationThe Medical Home for Children with Autism Spectrum Disorders: Parent and Pediatrician Perspectives
Carbone, P. S., Behl, D. D., Azor, V., & Murphy, N. A. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-009-0874-5 · Cited by 254
Cultural Influences on Perceptions of Health, Illness, and Disability: A Review and Focus on Autism
Ravindran, N., & Myers, B. J. (2012) · Journal of Child and Family Studies · doi:10.1007/s10826-011-9477-9 · Cited by 240
Metadata
- Authors
- Levy, S. E., & Hyman, S. L.
- Venue
- Child and Adolescent Psychiatric Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 17
- Issue
- 4
- Pages
- 803-820
- ISSN
- 1056-4993 (ISSN-L)
- OpenAlex
- W2039424378
- Cited by
- 208
- References
- 27
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.